Relationship Between Advanced Oxidation Protein Products, Advanced Glycation End Products, and S-Nitrosylated Proteins With Biological Risk and MDR-1 Polymorphisms in Patients Affected by B-Chronic Lymphocytic Leukemia

Author： Gangemi Sebastiano   Allegra Alessandro   Aguennouz Mohamed   Alonci Andrea   Speciale Antonio   Cannavò Antonino   Cristani Mariateresa   Russo Sabina   Spatari Giovanna   Alibrandi Angela   Musolino Caterina  

Publisher： Informa Healthcare

ISSN： 0735-7907

Source： Cancer Investigation, Vol.30, Iss.1, 2012-01, pp. : 20-26

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Receptor for Advanced Glycation End Products (RAGE)—Soluble Form (sRAGE) and Gene Polymorphisms in Patients with Breast Cancer

By Tesarova Petra   Kalousova Marta   Jachymova Marie   Mestek Oto   Petruzelka Lubos   Zima Tomas  

Cancer Investigation, Vol. 25, Iss. 8, 2007-11 ,pp. : 720-725

Informa Healthcare

Access to resources Recommend Favorite

Effect of advanced glycation end products on the expression of hypoxia-inducible factor-1α and vascular endothelial growth factor proteins in RF/6A cells

By            

Experimental and Therapeutic Medicine, Vol. 5, Iss. 5, 2013-01 ,pp. : 1519-1522

Spandidos Publications

Access to resources Recommend Favorite

Advanced glycation end products upregulate angiopoietin-like protein 4 expression by activating the renin-angiotensin system in endothelial cells

By              

Biomedical Reports, Vol. 3, Iss. 4, 2015-01 ,pp. : 578-582

Science Publishers

Access to resources Recommend Favorite

Expression of Receptor for Advanced Glycation End Products (RAGE) is Related to Prognosis in Patients with Esophageal Squamous Cell Carcinoma

By Tateno Taro  

Annals of Surgical Oncology, Vol. 16, Iss. 2, 2009-02 ,pp. : 440-446

Springer Publishing Company

Access to resources Recommend Favorite

S100A7 promotes the migration and invasion of osteosarcoma cells via the receptor for advanced glycation end products

By Kataoka Ken   Ono Tomoyuki   Murata Hitoshi   Morishita Mika   Yamamoto Ken-Ichi   Sakaguchi Masakiyo   Huh Nam-Ho  

Oncology Letters, Vol. 3, Iss. 5, 2012-05 ,pp. : 1149-1153

Spandidos Publications

Access to resources Recommend Favorite